Scholarly Index
Surender Kharbanda
Karyopharm Therapeutics (United States); 17,935 total citations; 210 total publications; best world rank #317
Karyopharm Therapeutics (United States)
17,935Total citations
210Total publications
72H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Chronic Myeloid Leukemia Treatments | Lifetime | 317 | US 162 | 98.48 |
| Cell death mechanisms and regulation | Lifetime | 317 | US 129 | 97.55 |
| Protein Kinase Regulation and GTPase Signaling | Lifetime | 758 | US 388 | 95.36 |
| Melanoma and MAPK Pathways | Lifetime | 616 | US 312 | 94.13 |
| Fungal Plant Pathogen Control | Lifetime | 439 | US 109 | 93.19 |
| Quinazolinone synthesis and applications | Lifetime | 731 | US 125 | 90.49 |